Comparison

SARS-CoV-2 NCAP A2 (N223-231) European Partner

Item no. EP07975_1
Manufacturer peptides & elephants
Amount 1 mg
Category
Type Peptides
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias RLLGKESQL B-lymphocyte antigen CD20 HLA-A*02:01
Available
Description
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells.
Keywords
RLLGKESQL B-lymphocyte antigen CD20 HLA-A*02:01
Sequence
RLLGKESQL
N-Terminus
H
C-Terminus
NH2
Purity
0, 95
Counter-Ion
TFA
Protein
B-lymphocyte antigen CD20
Gene
MS4A1
Allele
HLA-A*02:01
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close